These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 36307161)
1. Stroke prevention of thoracoscopic left atrial appendage clipping in patients with non-valvular atrial fibrillation at high risk of stroke and bleeding: study protocol for a non-randomised controlled clinical trial. Ye C; Han X; Chen Y; Liu F; Ma H; Yang Y; Liu Y; Hu Q; Yao Q; Xie W; Xu D BMJ Open; 2022 Oct; 12(10):e063931. PubMed ID: 36307161 [TBL] [Abstract][Full Text] [Related]
2. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY; J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585 [TBL] [Abstract][Full Text] [Related]
3. Epicardial left atrial appendage clipping versus direct oral anticoagulant to reduce stroke risk in non-paroxysmal atrial fibrillation (LAA-CLIP): rationale, design and study protocol for a multicentre randomised controlled trial. Yu C; Li H; Lei C; Wang Y; Chen S; Zhao Y; Zheng Z BMJ Open; 2024 Mar; 14(3):e083153. PubMed ID: 38448081 [TBL] [Abstract][Full Text] [Related]
4. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience. Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514 [TBL] [Abstract][Full Text] [Related]
5. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation. Kar S; Doshi SK; Alkhouli M; Camm AJ; Coylewright M; Gibson MC; Granger CB; Gurol ME; Huber K; Mansour M; Nair DG; Natale A; Pocock SJ; Reddy VR; Saliba W; Christen T; Allocco DJ; Ellenbogen KA; Leon MB Am Heart J; 2023 Oct; 264():123-132. PubMed ID: 37279840 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study. Tsiachris D; Papakonstantinou PE; Doundoulakis I; Tsioufis P; Botis M; Dimitriadis K; Leontsinis I; Kordalis A; Antoniou CK; Mantzouranis E; Iliakis P; Vlachakis PK; Gatzoulis KA; Tsioufis K Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893599 [No Abstract] [Full Text] [Related]
7. Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience. Zhao M; Post F; Muenzel M; Hou CR; Keil T; Yu J Int J Med Sci; 2021; 18(9):1990-1998. PubMed ID: 33850469 [TBL] [Abstract][Full Text] [Related]
8. Left Atrial Appendage Closure Versus Oral Anticoagulation in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. Al-Abcha A; Saleh Y; Elsayed M; Elshafie A; Herzallah K; Baloch ZQ; Banga S; Rayamajhi S; Abela GS Cardiovasc Revasc Med; 2022 Mar; 36():18-24. PubMed ID: 33903038 [TBL] [Abstract][Full Text] [Related]
9. Stand-Alone Left Atrial appendage occlusion for throMboembolism prevention in nonvalvular Atrial fibrillatioN DiseasE Registry (SALAMANDER): protocol for a prospective observational nationwide study. Kowalewski M; Wańha W; Litwinowicz R; Kołodziejczak M; Pasierski M; Januszek R; Kuźma Ł; Grygier M; Lesiak M; Kapłon-Cieślicka A; Reczuch K; Gil R; Pawłowski T; Bartuś K; Dobrzycki S; Lorusso R; Bartuś S; Deja MA; Smolka G; Wojakowski W; Suwalski P BMJ Open; 2022 Sep; 12(9):e063990. PubMed ID: 36130748 [TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcome of patients with left atrial appendage closure in China: a single-center experience. Zhang J; Li C; Zhou L; Sang C; Li S; Ma C BMC Cardiovasc Disord; 2024 Feb; 24(1):108. PubMed ID: 38355458 [TBL] [Abstract][Full Text] [Related]
11. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
12. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation. Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY; J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929 [TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of left atrial appendage closure in atrial fibrillation patients with different types of heart failure. Liu L; Yan W; Xu X; Wan C; Liu F; Yao Q; Song L; Wang B; Song Z; Li H BMC Cardiovasc Disord; 2024 Aug; 24(1):430. PubMed ID: 39148039 [TBL] [Abstract][Full Text] [Related]
14. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage. Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW; Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years. Yu J; Chen H; Post F; Muenzel M; Keil T; Hou CR; Zhao M; Meng Z; Jiang L Heart Vessels; 2019 Nov; 34(11):1858-1865. PubMed ID: 31144099 [TBL] [Abstract][Full Text] [Related]
16. Left atrial appendage occlusion for patients with valvular diseases without atrial fibrillation (the OPINION Study): study protocol for a multicentre, randomised controlled trial. Ju F; Yuan X; Sun H BMJ Open; 2024 Feb; 14(2):e076688. PubMed ID: 38326254 [TBL] [Abstract][Full Text] [Related]
17. Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure. Chen Y; Zhang Y; Qu L; Huang W; Su X; Chen Y J Thromb Thrombolysis; 2021 Oct; 52(3):872-879. PubMed ID: 33666825 [TBL] [Abstract][Full Text] [Related]
18. An Updated Meta-Analysis on the Clinical Outcomes of Percutaneous Left Atrial Appendage Closure Versus Direct Oral Anticoagulation in Patients With Atrial Fibrillation. Jiang H; Koh TH; Vengkat V; Fei G; Ding ZP; Ewe SH; Jappar I; Lim ST; Yap J Am J Cardiol; 2023 Aug; 200():135-143. PubMed ID: 37321026 [TBL] [Abstract][Full Text] [Related]
19. Lower rate of major bleeding in very high risk patients undergoing left atrial appendage occlusion: A propensity score-matched comparison with direct oral anticoagulant. Magnocavallo M; Della Rocca DG; Vetta G; Mohanty S; Gianni C; Polselli M; Rossi P; Parlavecchio A; Fazia MV; Guarracini F; De Vuono F; Bisignani A; Pannone L; Raposeiras-Roubín S; Lochy S; Cauti FM; Burkhardt JD; Boveda S; Sarkozy A; Sorgente A; Bianchi S; Chierchia GB; de Asmundis C; Al-Ahmad A; Di Biase L; Horton RP; Natale A Heart Rhythm; 2024 Aug; 21(8):1267-1276. PubMed ID: 38246567 [TBL] [Abstract][Full Text] [Related]
20. Less major bleeding and higher hemoglobin after left atrial appendage closure in high-risk patients: Data from a long-term, longitudinal, two-center observational study. Schach C; Reitschuster R; Benedikt D; Füssl E; Debl K; Maier LS; Luchner A Clin Cardiol; 2023 Nov; 46(11):1337-1344. PubMed ID: 37573576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]